{"disease":{"id":"c-kit-mutation","name":"c kit mutation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07143669","title":"Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations","phase":"","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Blueprint Medicines Corporation","has_results":false},{"nct_id":"NCT04811365","title":"(PROSPECTOR) Screening Study Evaluating the Prevalence of the KIT D816V Mutation in Patients With Systemic Mast Cell Activation","phase":"","overall_status":"COMPLETED","enrollment_count":379,"lead_sponsor_name":"Blueprint Medicines Corporation","has_results":false},{"nct_id":"NCT07028073","title":"A New Treatment of Newly Diagnosed KIT Mutation CBF-Acute Myeloid Leukemia","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":78,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT06116318","title":"A Study of c-Kit Mutation as MRD in Acute Myeloid Leukemia","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT05821738","title":"Avapritinib in CBF-AML With KIT Mutations","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT03560908","title":"Dasatinib Combined With Chemotherapy in Relapsed t(8;21) Acute Myeloid Leukemia With KIT D816 Mutation","phase":"PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}